Mandana Khalili

Chief of Clinical Hepatology, San Francisco General Hospital · University of California (San Francisco) School of Medicine

Credentials: · ·

History

Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $3.7M · University of California, San Francisco
2021–2027
NRSA Hepatology Training Grant
National Institute of Diabetes and Digestive and Kidney Diseases · T32
PI · $1.6M · University of California, San Francisco
2001–2027
Impact of the COVID-19 Pandemic on Patient Outcomes, Telehealth Care Delivery, and Treatment for Unhealthy Alcohol Use in Vulnerable Patients with Advanced Liver Disease Across Two Healthcare Systems
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $3.5M · University of California, San Francisco
2021–2027
Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease
National Institute on Alcohol Abuse and Alcoholism · K24
Contact PI · $1.9M · University of California, San Francisco
2013–2025

Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use
Principal investigator · Active not recruiting
University of California, San Francisco
2022–2026
Insulin Resistance in HCV Infection
Principal investigator · Active not recruiting
University of California, San Francisco
2008–2026
Natural History of Hepatitis C in Patients With Normal Liver Tests
Principal investigator · Completed
University of California, San Francisco
2000–2021